verified SJR 2,756 · Q1 • database Scopus / SJR & Web of Science indexed

Ireland · Elsevier Ireland Ltd

workspace_premium Q1 — Oncology lock Subscription

Cancer Letters

Cancer Letters is a journal indexed in SJR in Oncology and Cancer Research with an H index of 230. It has an SJR impact factor of 2,756 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,756.

Cancer Letters focuses its scope in these topics and keywords: cancer, cell, human, lung, tumor, signaling, activity, breast, immune, growth, ...

ISSN: 0304-3835

Publisher: Elsevier Ireland Ltd

Category: Oncology

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

2,756 Q1

H-index 230

Acceptance rate pie_chart

20% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

2,756

H-index

230

Docs (year)

565

Docs 3y

1156

Total refs

44871

Cites 3y

11123

Citable 3y

1135

Cites/Doc 2y

9.23

Ref/Doc

79.42

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Chemoprotective properties of chlorophyllin against vinyl carbamate, p-nitrophenyl vinyl ether and their electrophilic epoxides

Tumor growth enhancing effects of vascular endothelial growth factor are associated with increased nitric oxide synthase activity and inhibition of apoptosis in human breast carcinoma xenografts

Effects of cigarette smoke and disulfiram on tumorigenicity and clastogenicity of ethyl carbamate in mice

Effect of neoadjuvant chemotherapy for lymph node micrometastasis and tumor cell microinvolvement in the patients with esophageal carcinoma

Effect of cadmium on human ovarian cancer cells with acquired cisplatin resistance

Difference in prognostic value between sialyl Lewisa and sialyl Lewisx antigens in blood samples obtained from the drainage veins of the colorectal tumors

Dermal toxicity of topical (-)epigallocatechin-3-gallate in BALB/c and SKH1 mice

Corrigendum

Correlation of expression of CD44 isoforms and E-cadherin with differentiation in human urothelial cell lines and transitional cell carcinoma

Controversies in the local management of invasive and non-invasive breast cancer

Combination of immunotherapy with cyclophosphamide/actinomycin D chemotherapy potentiates antileukemic effect and reduces toxicity in a L1210 leukemia model in mice

Clonal analysis of benign and malignant human breast tumors by means of polymerase chain reaction

SHOW MORE ARTICLES

Chromosome aberrations as a predictor of clinical outcome for smoking associated lung cancer

5-Aminolevulinic acid induced lipid peroxidation after light exposure on human colon carcinoma cells and effects of a-tocopherol treatment

Chemopreventive activity of hydroksymatairesinol in adenomatous polyposis colimultiple intestinal neoplasia (Apc)Min mice

Cancer chemopreventive activity of phenylpropanoid esters of sucrose, vanicoside B and lapathoside A, from Polygonum lapathifolium

beta-Catenin and adenomatous polyposis coli (APC) mutations in adenomas from hereditary non-polyposis colorectal cancer patients

Anticarcinogenic effect of black tea on pulmonary tumors in Swiss albino mice

Altered composition of the AP-1 transcription factor in immortalized compared to normal proliferating cells

Activation of the beta-catenin gene by interstitial deletions involving exon 3 as an early event in colorectal tumorigenesis

Acceleration of chromosomal instability by loss of BRCA1 expression and p53 abnormality in sporadic breast cancers

Absence of hSNF5/INI1 mutation in human lung cancer

A new assay for lipiodol in a tumor using a combination of m-chloroperbenzoic acid-mediated oxidation and the iodo-starch reaction

A glutathione S-transferase inducer from papaya: rapid screening, identification and structure-activity relationship of isothiocyanates

FAQs

Cancer Letters has an SJR of 2,756 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Cancer Letters is 20%.

Cancer Letters

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Cancer Letters?

What is the APC / publication cost?

What is the acceptance rate?